EQT AB (publ) (BIT:1EQT)

Market Cap	35.47B
Revenue (ttm)	2.69B
Net Income (ttm)	840.30M
Shares Out	n/a
EPS (ttm)	0.71
PE Ratio	42.21
Forward PE	24.19
Dividend	2.35 (7.75%)
Ex-Dividend Date	Nov 28, 2025

Volume	n/a
Average Volume	n/a
Open	n/a
Previous Close	30.15
Day's Range	n/a
52-Week Range	20.85 - 30.44
Beta	n/a
RSI	58.55
Earnings Date	Jul 17, 2025

About Ligand Pharmaceuticals

EQT AB (publ) is a global private equity & venture capital firm specializing in private capital and real asset segments. The firm seeks to invest in seed, startup, turnaround, middle market, mature, early venture, emerging growth, mid venture, late venture, distressed/vulture, loan, secondary (direct) investments. The firm seeks to invest through growth, buyout and recapitalization in companies. It also invests in greenfund & fintech investments. The firm prefers to invest in financial services, engineering services, healthcare, IT services & s...

• Industry: Investors, not elsewhere classified
• Founded: 1994
• Employees: 1,937
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1EQT

Financial Performance

In 2024, EQT AB's revenue was 2.65 billion, an increase of 24.99% compared to the previous year's 2.12 billion. Earnings were 776.30 million, an increase of 362.36%.